101 filings
Page 2 of 6
6-K
pglbbywza06 ilqz
27 Oct 23
Current report (foreign)
6:04pm
6-K
3m99klzx
25 Oct 23
XORTX Announces Date for Rescheduled Special Meeting of Shareholders
5:00pm
6-K
x3qa6v j3
25 Oct 23
XORTX Announces Rescheduling of Special Meeting of Shareholders
7:00am
6-K
xm88dorzn1cz ytj
12 Oct 23
XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution
7:41am
6-K
r5w86cqhvam5 yk4bf
4 Oct 23
XORTX Calls Special Meeting of Shareholders
1:11pm
6-K
fty meqj9scp
4 Oct 23
Notice of Special Meeting of Shareholders
7:00am
6-K
efet l8fxiutux05
28 Sep 23
XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2023
7:56am
6-K
8v4pywk3fys2kc6
12 Sep 23
XORTX Announces Participation at Upcoming Investor Conferences
3:56pm
6-K
f5osqwfkv60xcys
7 Sep 23
XORTX Joins the Kidney Foundation and Kidney March
8:23am
6-K
4ir8tvd5pzzgm8aafzyb
29 Aug 23
XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease
7:00am
6-K
3fbq9hvgg4bj 5vf
15 Aug 23
Condensed Interim Consolidated Financial Statements
6:00am
6-K
ywjcqa szmxl6h0
4 Aug 23
XORTX Appoints Chief Financial Officer
5:00pm
6-K
lhzx8r oplh
29 Jun 23
Current report (foreign)
7:43pm
6-K
mc6vq5twdreanrx
29 Jun 23
XORTX Announces Results of Annual and Special Meeting of Shareholders
8:02am
6-K
eowsup3
27 Jun 23
XORTX Reminds Shareholders to Vote ahead of the Proxy Voting Deadline for the Company’s Upcoming Annual and Special Meeting of Shareholders
2:15pm
6-K
n7rq dks2ykfl4s8
6 Jun 23
XORTX Announces PKD Presentation
7:00am
6-K
pxrfd950r2 5rhwn
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
6-K
hbyo3x wum
24 May 23
XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
7:00am
6-K
qvlvtt951
16 May 23
Condensed Interim Consolidated Financial Statements
9:32am
6-K
7ihe7b 8o
4 May 23
FDA Confirms Eligibility of XORLO™ for Accelerated Approval
7:00am